T2D patients with diabetic micro-angiopathic complications have higher soluble ICAM1 levels in comparison with diabetic group without micro-angiopathic complications and healthy control subjects (Mastej and Adamiec, 2008). The gene discussed is ICAM1; the disease is type 2 diabetes mellitus.